| Primary |
| Drug Use For Unknown Indication |
100.0% |
|
| Dermatitis Contact |
66.7% |
| Bone Marrow Failure |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
22.6% |
| Drug Use For Unknown Indication |
21.4% |
| Back Pain |
10.8% |
| Hypertension |
5.0% |
| Sciatica |
4.6% |
| Type 2 Diabetes Mellitus |
3.9% |
| Parkinson's Disease |
3.5% |
| Pain |
3.3% |
| Ill-defined Disorder |
2.9% |
| Anaesthesia |
2.7% |
| Arthralgia |
2.5% |
| Dyslipidaemia |
2.3% |
| Psoriatic Arthropathy |
2.3% |
| Diabetes Mellitus |
2.1% |
| Neuralgia |
2.1% |
| Infection Prophylaxis |
1.9% |
| Multiple Myeloma |
1.9% |
| Depression |
1.7% |
| Prophylaxis |
1.5% |
| Myalgia |
1.2% |
|
| Pathological Fracture |
14.7% |
| Toxic Skin Eruption |
9.3% |
| Malaise |
6.7% |
| Renal Failure Acute |
6.7% |
| Rash Papular |
5.3% |
| Somnolence |
5.3% |
| Toxic Epidermal Necrolysis |
5.3% |
| Wegener's Granulomatosis |
5.3% |
| Acute Generalised Exanthematous Pustulosis |
4.0% |
| Hepatitis Cholestatic |
4.0% |
| Pierre Robin Syndrome |
4.0% |
| Pyrexia |
4.0% |
| Septic Shock |
4.0% |
| Stevens-johnson Syndrome |
4.0% |
| Vomiting |
4.0% |
| Cytolytic Hepatitis |
2.7% |
| Dermatitis Exfoliative |
2.7% |
| Erythema Multiforme |
2.7% |
| Grand Mal Convulsion |
2.7% |
| Lichenoid Keratosis |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.4% |
| Product Used For Unknown Indication |
11.2% |
| Pain |
9.9% |
| Prophylaxis |
8.0% |
| Rheumatoid Arthritis |
6.7% |
| Back Pain |
5.7% |
| Osteoporosis |
4.0% |
| Hypertension |
3.5% |
| Depression |
3.4% |
| Unevaluable Event |
3.0% |
| Breast Cancer |
2.9% |
| Thrombosis Prophylaxis |
2.9% |
| Non-small Cell Lung Cancer |
2.7% |
| Bone Pain |
2.6% |
| Anxiety |
2.5% |
| Neuralgia |
2.5% |
| Multiple Myeloma |
2.4% |
| Insomnia |
2.2% |
| Pseudomonas Infection |
2.2% |
| Staphylococcal Infection |
2.2% |
|
| Vomiting |
11.1% |
| Pulmonary Embolism |
7.1% |
| Confusional State |
6.1% |
| Rectal Haemorrhage |
6.1% |
| Neutropenia |
5.1% |
| Pancytopenia |
5.1% |
| Pyrexia |
5.1% |
| Renal Failure Acute |
5.1% |
| Sepsis |
5.1% |
| Tachycardia |
5.1% |
| Thrombocytopenic Purpura |
5.1% |
| Aortic Aneurysm |
4.0% |
| Haematoma |
4.0% |
| Hepatocellular Injury |
4.0% |
| Hypertension |
4.0% |
| Tendon Rupture |
4.0% |
| Weight Decreased |
4.0% |
| Weight Increased |
4.0% |
| Deep Vein Thrombosis |
3.0% |
| General Physical Health Deterioration |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
25.0% |
| Depression |
16.7% |
| Muscle Contracture |
16.7% |
| Sciatica |
16.7% |
| Drug Use For Unknown Indication |
8.3% |
| Dysthymic Disorder |
8.3% |
| Hypertension |
8.3% |
|
| Dizziness |
20.0% |
| Drug Interaction |
20.0% |
| Hypoxic-ischaemic Encephalopathy |
20.0% |
| International Normalised Ratio Increased |
20.0% |
| Orthostatic Hypotension |
20.0% |
|
